Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T18:10:23.178Z Has data issue: false hasContentIssue false

Predicting treatment resistance in people with a first-episode of psychosis using commonly recorded clinical information

Published online by Cambridge University Press:  01 September 2022

E.F. Osimo*
Affiliation:
University of Cambridge, Dept Of Psychiatry, Cambridge, United Kingdom Imperial College London, Institute Of Clinical Sciences, London, United Kingdom
B. Perry
Affiliation:
University of Cambridge, Dept Of Psychiatry, Cambridge, United Kingdom
P. Mallikarjun
Affiliation:
University of Birmingham, Institute Of Clinical Sciences, Birmingham, United Kingdom
G. Murray
Affiliation:
University of Cambridge, Dept Of Psychiatry, Cambridge, United Kingdom
O. Howes
Affiliation:
King’s College London, Psychiatry, London, United Kingdom
P. Jones
Affiliation:
University of Cambridge, Dept Of Psychiatry, Cambridge, United Kingdom
R. Upthegrove
Affiliation:
University of Birmingham, Institute Of Clinical Sciences, Birmingham, United Kingdom
G. Khandaker
Affiliation:
University of Cambridge, Dept Of Psychiatry, Cambridge, United Kingdom
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

23% of people experiencing a first episode of psychosis (FEP) develop treatment resistant schizophrenia (TRS). At present, there are no established methods to accurately identify who will develop TRS from baseline.

Objectives

In this study we used patient data from three UK early intervention services (EIS) to investigate the predictive potential of routinely recorded sociodemographic, lifestyle and biological data at FEP baseline for the risk of TRS up to six years later.

Methods

We developed two risk prediction algorithms to predict the risk of TRS at 2-8 years from FEP onset using commonly recorded information at baseline. Using the forced-entry method, we created a model including age, sex, ethnicity, triglycerides, alkaline phosphatase levels and lymphocyte counts. We also produced a machine-learning-based model, including an additional four variables. The models were developed using data from two and externally validated in another UK psychosis EIS.

Results

The development samples included 785 patients, and 1,110 were included in the validation sample. The models discriminated TRS well at internal validation (forced-entry: C 0.70, 95%CI 0.63-0.76; LASSO: C 0.69, 95%CI 0.63-0.77). At external validation, discrimination performance attenuated (forced-entry: C 0.63, 0.58-0.69; LASSO: C 0.64, 0.58-0.69) but recovered for the forced entry model after recalibration and revision of the lymphocyte predictor (C: 0.67, 0.62-0.73).

Conclusions

The use of commonly recorded clinical information including biomarkers taken at FEP onset could help to predict TRS. These measures should be considered in future studies modelling psychiatric outcomes.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.